Methods and apparatus for bilateral renal neuromodulation

US10179235B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10179235-B2
Application numberUS-201715729326-A
CountryUS
Kind codeB2
Filing dateOct 10, 2017
Priority dateApr 8, 2002
Publication dateJan 15, 2019
Grant dateJan 15, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and apparatus are provided for bilateral renal neuromodulation, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.

First claim

Opening claim text (preview).

We claim: 1. A method for treatment of a hypertensive human patient, the method comprising: intravascularly positioning a catheter within a first renal artery associated with a first kidney of the patient; ablating renal nerves along the first renal artery via first ultrasound energy from the catheter; intravascularly positioning the catheter within a second renal artery associated with a second kidney of the patient; and ablating renal nerves along the second renal artery via second ultrasound energy from the catheter, wherein ablating renal nerves along the first renal artery and ablating renal nerves along the second renal artery results in a therapeutically beneficial reduction in blood pressure of the hypertensive patient. 2. The method of claim 1 , further comprising removing the catheter from the patient after delivering the first and second ultrasound energy to conclude the procedure. 3. The method of claim 1 wherein the first ultrasound energy is the same as the second ultrasound energy. 4. The method of claim 1 wherein the first ultrasound energy and the second ultrasound energy are both high frequency ultrasound energy. 5. The method of claim 1 wherein ablating renal nerves along the first renal artery and ablating renal nerves along the second renal artery further results in a therapeutically beneficial reduction in central sympathetic overactivity of the patient. 6. A method for treating a hypertensive human patient, the method comprising: intravascularly positioning a first catheter within a first renal blood vessel of the patient and adjacent to renal nerves innervating a first kidney of the patient; delivering, via the first catheter, first ultrasound energy to the renal nerves disposed adjacent to the first renal blood vessel, wherein the first ultrasound energy attenuates neural traffic along the renal nerves innervating the first kidney; intravascularly positioning a second catheter within a second renal blood vessel of the patient and adjacent to renal nerves innervating a second kidney of the patient; delivering, via the second catheter, second ultrasound energy to the renal nerves disposed adjacent to the second renal blood vessel, wherein the second ultrasound energy attenuates neural traffic along the renal nerves innervating the second kidney, wherein attenuating neural traffic along the renal nerves innervating the first kidney and renal nerves innervating the second kidney results in a therapeutically beneficial improvement in one or more physiological conditions associated with hypertension of the patient. 7. The method of claim 6 wherein intravascularly positioning the first catheter within the first renal blood vessel of the patient and intravascularly positioning the second catheter within the second renal blood vessel of the patient occur simultaneously. 8. The method of claim 6 wherein: intravascularly positioning a first catheter within a first renal blood vessel of the patient comprises intravascularly delivering the first catheter to the first renal blood vessel over a first guidewire; and intravascularly positioning a second catheter within a second renal blood vessel of the patient comprises intravascularly delivering the second catheter to the second renal blood vessel over a second guidewire. 9. The method of claim 6 , further comprising removing the first catheter from the first renal blood vessel of the patient before positioning the second catheter within the second renal blood vessel of the patient. 10. The method of claim 6 wherein: attenuating neural traffic along the renal nerves innervating the first kidney comprises ablating the renal nerves innervating the first kidney; and attenuating neural traffic along the renal nerves innervating the second kidney comprises ablating the renal nerves innervating the second kidney. 11. The method of claim 6 wherein: attenuating neural traffic along the renal nerves innervating the first kidney comprises partially ablating the renal nerves innervating the first kidney; and attenuating neural traffic along the renal nerves innervating the second kidney comprises partially ablating the renal nerves innervating the second kidney. 12. The method of claim 6 wherein: attenuating neural traffic along the renal nerves innervating the first kidney comprises reducing renal sympathetic nerve activity of the first kidney; and attenuating neural traffic along the renal nerves innervating the second kidney comprises reducing renal sympathetic nerve activity of the second kidney. 13. The method of claim 6 wherein attenuating neural traffic along the renal nerves innervating the first kidney and the renal nerves innervating the second kidney results in a therapeutically beneficial reduction in central sympathetic overactivity of the patient. 14. The method of claim 6 wherein the first ultrasound energy is the same as the second ultrasound energy. 15. The method of claim 6 wherein the first ultrasound energy is high frequency ultrasound energy. 16. The method of claim 6 wherein intravascularly positioning the first catheter within the first renal blood vessel of the patient and intravascularly positioning the second catheter within the second renal blood vessel of the patient occur sequentially.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10179235B2 cover?
Methods and apparatus are provided for bilateral renal neuromodulation, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action poten…
Who is the assignee on this patent?
Medtronic Ardian Luxembourg
What technology area does this patent fall under?
Primary CPC classification A61N1/0551. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).